JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamauchi, H.
Right arrow Articles by Kagawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamauchi, H.
Right arrow Articles by Kagawa, S.
Journal of Nuclear Medicine Vol. 46 No. 12 1973-1979
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Selective Neuronal Damage and Borderzone Infarction in Carotid Artery Occlusive Disease: A 11C-Flumazenil PET Study

Hiroshi Yamauchi, MD, PhD1, Takashi Kudoh, MD, PhD1, Yoshihiko Kishibe1, Jinei Iwasaki1 and Shinya Kagawa, MS1

1 Research Institute, Shiga Medical Center, Moriyama, Japan

The pathogenesis of selective neuronal damage in internal carotid artery (ICA) occlusive disease is unclear. Imaging of the central-type benzodiazepine receptor (BZR), which is expressed by most cortical neurons, provides information on the neuronal alterations induced by ischemia in vivo. Hemodynamic ischemia due to ICA occlusive disease may cause not only borderzone infarction but also selective neuronal damage beyond the regions of infarcts, which may be detected by a decrease in BZR in the normal-appearing cerebral cortex. The purpose of this study was to determine whether selective neuronal damage is associated with borderzone infarction in ICA occlusive disease. Methods: We measured BZR using PET and 11C-flumazenil in 62 nondisabled patients with ICA steno-occlusive lesions in the chronic stage. Flumazenil binding potential (BP) was calculated using the dynamic data and the reference tissue model. The infarcts on MRI—which were categorized as territorial, borderzone (external or internal), striatocapsular, lacunar, and other white matter infarcts—were correlated with the mean cerebral/cerebellar cortical BP ratio in the hemisphere with ICA occlusive disease. Results: Patients with borderzone infarction (n = 18) had a significantly decreased flumazenil BP ratio in the hemisphere with ICA occlusive disease compared with patients without borderzone infarction (n = 44) and healthy control subjects (n = 10). Multivariate analysis showed that external borderzone infarction was an independent predictor of the decreased flumazenil BP ratio. Conclusion: In ICA occlusive disease, selective neuronal damage demonstrated as decreased BZR is associated with borderzone infarction, suggesting that hemodynamic ischemia leading to borderzone infarction may cause selective neuronal damage beyond the regions of infarcts in the chronic stage.

Key Words: benzodiazepine receptors • borderzone infarct • carotid artery disease • emission tomography, computed


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 7a-8a. [Full Text]  



This article has been cited by other articles:


Home page
BrainHome page
J. V. Guadagno, P. S. Jones, F. I. Aigbirhio, D. Wang, T. D. Fryer, D. J. Day, N. Antoun, I. Nimmo-Smith, E. A. Warburton, and J. C. Baron
Selective neuronal loss in rescued penumbra relates to initial hypoperfusion
Brain, October 1, 2008; 131(10): 2666 - 2678.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Giffard, B. Landeau, N. Kerrouche, A. R. Young, L. Barre, and J.-C. Baron
Decreased Chronic-Stage Cortical 11C-Flumazenil Binding After Focal Ischemia-Reperfusion in Baboons: A Marker of Selective Neuronal Loss?
Stroke, March 1, 2008; 39(3): 991 - 999.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W.-D. Heiss and A. G. Sorensen
Advances in Imaging 2006
Stroke, February 1, 2007; 38(2): 238 - 240.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.